The DOI matches its Crossref record; 108 of the 108 references it cites were found in a registry or an index.
Risk Factors for Herpes Zoster Infection: A Meta-Analysis
Open accessAbstract
Background: The burden of herpes zoster (HZ) is significant worldwide, with millions affected and the incidence rising. Current literature has identified some risk factors for this disease; however, there is yet to be a comprehensive study that pools all evidence to provide estimates of risk. Therefore, the purpose of this study is to identify various risk factors, excluding immunosuppressive medication, that may predispose an individual to developing HZ. Methods: The literature search was conducted in MEDLINE, EMBASE, and Cochrane Central, yielding case control, cohort, and cross-sectional studies that were pooled from January 1966 to September 2017. Search terms included the following: zoster OR herpe* OR postherpe* OR shingle* AND risk OR immunosupp* OR stress OR trauma OR gender OR ethnicity OR race OR age OR diabetes OR asthma OR chronic obstructive pulmonary disease OR diabetes. Risk ratios (RRs) for key risk factors were calculated via natural logarithms and pooled using random-effects modeling. Results: From a total of 4417 identified studies, 88 were included in analysis (N = 3, 768 691 HZ cases). Immunosuppression through human immunodeficiency virus/acquired immune deficiency syndrome (RR = 3.22; 95% confidence interval [CI], 2.40–4.33) or malignancy (RR = 2.17; 95% CI, 1.86–2.53) significantly increased the risk of HZ compared with controls. Family history was also associated with a greater risk (RR = 2.48; 95% CI, 1.70–3.60), followed by physical trauma (RR = 2.01; 95% CI, 1.39–2.91) and older age (RR = 1.65; 95% CI, 1.37–1.97). A slightly smaller risk was seen those with psychological stress, females, and comorbidities such as diabetes, rheumatoid arthritis, cardiovascular diseases, renal disease, systemic lupus erythematosus, and inflammatory bowel disease compared with controls (RR range, 2.08–1.23). We found that black race had lower rates of HZ development (RR = 0.69; 95% CI, 0.56–0.85). Conclusions: This study demonstrated a number of risk factors for development of HZ infection. However, many of these characteristics are known well in advance by the patient and clinician and may be used to guide discussions with patients for prevention by vaccination.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Dermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., & Zhang, T. (2017) · Neonatology · doi:10.1159/000454668 · Cited by 24,451
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
Funnel plots for detecting bias in meta-analysis
Sterne, J. A. C., & Egger, M. (2001) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(01)00377-8 · Cited by 3,779 · cited 1×
“Using funnel plots, publication bias was assessed, and asymmetry was assessed by conducting the Egger test [19].”
MethodA Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older Adults
Oxman, M. N., Levin, M. J., Johnson, G. R., Schmader, K. E., Straus, S. E., Gelb, L. D., Arbeit, R. D., Simberkoff, M. S., Gershon, A. A., Davis, L. E., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051016 · Cited by 2,412
Epidemiology: Beyond the Basics
Szklo, M., & Nieto, F. J. (1999) · Cited by 1,441
The Nature of Herpes Zoster: A Long-Term Study and a New Hypothesis
Hope-Simpson, R. E. (1965) · Proceedings of the Royal Society of Medicine · doi:10.1177/003591576505800106 · Cited by 1,386
Epidemiology: Beyond the Basics
Szklo, M. (2001) · American Journal of Epidemiology · doi:10.1093/aje/153.8.821 · Cited by 1,310
RNAi-Mediated Chromatin Silencing in Fission Yeast
White, S. A., & Allshire, R. C. (2008) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-540-75157-1_8 · Cited by 971
Systematic review of incidence and complications of herpes zoster: towards a global perspective
Kawai, K., Gebremeskel, B. G., & Acosta, C. J. (2014) · BMJ Open · doi:10.1136/bmjopen-2014-004833 · Cited by 938
Immunosenescence: emerging challenges for an ageing population
Aw, D., Silva, A. B., & Palmer, D. B. (2007) · Immunology · doi:10.1111/j.1365-2567.2007.02555.x · Cited by 880 · cited 1×
“4 • ofid • Marra et al The elevated risk in the older patients is likely due to immunosenescence, in which the immune system progressively deteriorates as individuals age [108].”
BackgroundYawn, B. P., Saddier, P., Wollan, P. C., Sauver, J. L. S., Kurland, M. J., & Sy, L. S. (2007) · Mayo Clinic Proceedings · doi:10.4065/82.11.1341 · Cited by 867
Cohen, J. I. (2013) · New England Journal of Medicine · doi:10.1056/nejmcp1302674 · Cited by 734
Postherpetic Neuralgia — Pathogenesis, Treatment, and Prevention
Kost, R. G., & Straus, S. E. (1996) · New England Journal of Medicine · doi:10.1056/nejm199607043350107 · Cited by 641
Racial and Ethnic Differences in Access to Medical Care
Mayberry, R. M., Mili, F., & Ofili, E. (2000) · Medical Care Research and Review · doi:10.1177/1077558700057001s06 · Cited by 610
What does epidemiology tell us about risk factors for herpes zoster?
Thomas, S. L., & Hall, A. J. (2004) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00857-0 · Cited by 561
Weller, T. H. (1983) · New England Journal of Medicine · doi:10.1056/nejm198312013092205 · Cited by 493
Understanding heterogeneity in meta-analysis: the role of meta-regression
Baker, W. L., Michael White, C., Cappelleri, J. C., Kluger, J., Coleman, C. I., & From the Health Outcomes, P. (2009) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2009.02168.x · Cited by 492
The incidence of herpes zoster in a United States administrative database
Insinga, R. P., Itzler, R. F., Pellissier, J. M., Saddier, P., & Nikas, A. A. (2005) · Journal of General Internal Medicine · doi:10.1111/j.1525-1497.2005.0150.x · Cited by 490
Risk Factors for Herpes Zoster: A Systematic Review and Meta-analysis
Kawai, K., & Yawn, B. P. (2017) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2017.10.009 · Cited by 310
Herpes Zoster and Human Immunodeficiency Virus Infection
Buchbinder, S. P., Katz, M. H., Hessol, N. A., Liu, J. Y., O'Malley, P. M., Underwood, R., & Holmberg, S. D. (1992) · Journal of Infectious Diseases · doi:10.1093/infdis/166.5.1153 · Cited by 309
Smitten, A. L., Choi, H. K., Hochberg, M. C., Suissa, S., Simon, T. A., Testa, M. A., & Chan, K. A. (2007) · Arthritis Care & Research · doi:10.1002/art.23112 · Cited by 281
Quantification of risk factors for herpes zoster: population based case-control study
Forbes, H. J., Bhaskaran, K., Thomas, S. L., Smeeth, L., Clayton, T., & Langan, S. M. (2014) · BMJ · doi:10.1136/bmj.g2911 · Cited by 267
Similar herpes zoster incidence across Europe: results from a systematic literature review
Pinchinat, S., Cebrián-Cuenca, A. M., Bricout, H., & Johnson, R. W. (2013) · BMC Infectious Diseases · doi:10.1186/1471-2334-13-170 · Cited by 245
Herpes Zoster Vaccine in Older Adults and the Risk of Subsequent Herpes Zoster Disease
Tseng, H. F. (2011) · JAMA · doi:10.1001/jama.2010.1983 · Cited by 239
Incidence and Risk Factors for Herpes Zoster Among Patients With Inflammatory Bowel Disease
Gupta, G., Lautenbach, E., & Lewis, J. D. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.09.019 · Cited by 208
Langan, S. M., Smeeth, L., Margolis, D. J., & Thomas, S. L. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001420 · Cited by 203
Incidence of herpes zoster in patients with altered immune function
Chen, S.-Y., Suaya, J. A., Li, Q., Galindo, C. M., Misurski, D., Burstin, S., & Levin, M. J. (2014) · Infection · doi:10.1007/s15010-013-0550-8 · Cited by 198
Increased risk of herpes zoster among 108 604 patients with inflammatory bowel disease
Long, M. D., Martin, C., Sandler, R. S., & Kappelman, M. D. (2013) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12182 · Cited by 186
Herpes Zoster Eye Complications: Rates and Trends
Yawn, B. P., Wollan, P. C., St. Sauver, J. L., & Butterfield, L. C. (2013) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2013.03.014 · Cited by 176
Gialloreti, L. E., Merito, M., Pezzotti, P., Naldi, L., Gatti, A., Beillat, M., Serradell, L., di Marzo, R., & Volpi, A. (2010) · BMC Infectious Diseases · doi:10.1186/1471-2334-10-230 · Cited by 174
Weller, T. H. (1983) · New England Journal of Medicine · doi:10.1056/nejm198312083092306 · Cited by 173
Hata, A., Kuniyoshi, M., & Ohkusa, Y. (2011) · Infection · doi:10.1007/s15010-011-0162-0 · Cited by 170
Incidence of herpes zoster, 1997–2002
MULLOOLY, J. P., RIEDLINGER, K., CHUN, C., WEINMANN, S., & HOUSTON, H. (2005) · Epidemiology and Infection · doi:10.1017/s095026880400281x · Cited by 165
Examination of Links Between Herpes Zoster Incidence and Childhood Varicella Vaccination
Hales, C. M., Harpaz, R., Joesoef, M. R., & Bialek, S. R. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-159-11-201312030-00006 · Cited by 151
Racial Differences In The Occurrence Of Herpes Zoster
Schmader, K. E., George, L. K., Burchett, B. M., Pieper, C. F., & Hamilton, J. D. (1995) · The Journal of Infectious Diseases · doi:10.1093/infdis/171.3.701 · Cited by 147
Annual incidence rates of herpes zoster among an immunocompetent population in the United States
Johnson, B. H., Palmer, L. A., Gatwood, J. D., Lenhart, G. M., Kawai, K., & Acosta, C. J. (2015) · BMC Infectious Diseases · doi:10.1186/s12879-015-1262-8 · Cited by 141
Diabetes as a Risk Factor for Herpes Zoster Infection: Results of a Population-Based Study in Israel
Heymann, A. D., Chodick, G., Karpati, T., Kamer, L., Kremer, E., Green, M. S., Kokia, E. S., & Shalev, V. (2008) · Infection · doi:10.1007/s15010-007-6347-x · Cited by 138
Marra, F., Lo, E. A., Kalashnikov, V., & Richardson, K. (2016) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofw205 · Cited by 124
Self-citationEpidemiological Features and Costs of Herpes Zoster in Taiwan: a National Study 2000 to 2006
Jih, J., Chen, Y., Lin, M., Chen, Y., Chen, T., Huang, Y., Chen, C., Lee, D.-D., Chang, Y., Wang, W., et al. (2009) · Acta Dermato Venereologica · doi:10.2340/00015555-0729 · Cited by 122
Herpes zoster in Germany: Quantifying the burden of disease
Ultsch, B., Siedler, A., Rieck, T., Reinhold, T., Krause, G., & Wichmann, O. (2011) · BMC Infectious Diseases · doi:10.1186/1471-2334-11-173 · Cited by 122
Herpes zoster pathogenesis and cell-mediated immunity and immunosenescence.
Oxman, M. N. (2009) · PubMed · Cited by 119
A population based study of the epidemiology of Herpes Zoster and its complications
Weitzman, D., Shavit, O., Stein, M., Cohen, R., Chodick, G., & Shalev, V. (2013) · Journal of Infection · doi:10.1016/j.jinf.2013.06.016 · Cited by 116
Incidence and Time Trends of Herpes Zoster in Rheumatoid Arthritis: A Population‐Based Cohort Study
Veetil, B. M. A., Myasoedova, E., Matteson, E. L., Gabriel, S. E., Green, A. B., & Crowson, C. S. (2012) · Arthritis Care & Research · doi:10.1002/acr.21928 · Cited by 108
Chronic Medical Conditions as Risk Factors for Herpes Zoster
Joesoef, R. M., Harpaz, R., Leung, J. W. T., & Bialek, S. R. (2012) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2012.05.021 · Cited by 105
Incidence of Herpes Zoster Ophthalmicus: Results from the Pacific Ocular Inflammation Study
Borkar, D. S., Tham, V. M., Esterberg, E. J., Ray, K. J., Vinoya, A. C., Parker, J. V., Uchida, A., & Acharya, N. R. (2012) · Ophthalmology · doi:10.1016/j.ophtha.2012.09.007 · Cited by 101
Yang, Y., Chen, Y.-H., Wang, K.-H., Wang, C., & Lin, H.-W. (2011) · Canadian Medical Association Journal · doi:10.1503/cmaj.101137 · Cited by 99
Arvin, A. M. (2000) · Transplantation and Cellular Therapy · doi:10.1016/s1083-8791(00)70004-8 · Cited by 95
Race and Stress in the Incidence of Herpes Zoster in Older Adults
Schmader, K. E., George, L. K., Burchett, B. M., Hamilton, J. D., & Pieper, C. F. (1998) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1998.tb02751.x · Cited by 94
Philip, A. G., & Thakur, R. (2011) · Journal of Palliative Medicine · doi:10.1089/jpm.2011.9685 · Cited by 90
Family History as a Risk Factor for Herpes Zoster
Hicks, L. D., Cook‐Norris, R. H., Mendoza, N., Madkan, V. K., Arora, A., & Tyring, S. K. (2008) · Archives of Dermatology · doi:10.1001/archderm.144.5.603 · Cited by 88
Risk and impact of herpes zoster on patients with diabetes: A population-based study, 2009–2014
Muñoz-Quiles, C., López‐Lacort, M., Ampudia‐Blasco, F. J., & Díez‐Domingo, J. (2017) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2017.1368600 · Cited by 87
Herpes Zoster Among Persons Living With HIV in the Current Antiretroviral Therapy Era
Blank, L. J., Polydefkis, M. J., Moore, R. D., & Gebo, K. A. (2012) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e318266cd3c · Cited by 85
Takao, Y., Miyazaki, Y., Okeda, M., Onishi, F., Yano, S., Gomi, Y., Ishikawa, T., Okuno, Y., Mori, Y., Asada, H., et al. (2015) · Journal of Epidemiology · doi:10.2188/jea.je20140210 · Cited by 80
Herpes zoster risk after 21 specific cancers: population-based case–control study
Hansson, E., Forbes, H. J., Langan, S., Smeeth, L. L., & Bhaskaran, K. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.124 · Cited by 79
Suaya, J. A., Chen, S., Li, Q., Burstin, S. J., & Levin, M. J. (2014) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofu049 · Cited by 77
Tanuseputro, P., Zagorski, B., Chan, K. J., & Kwong, J. C. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.09.024 · Cited by 76
Herpes zoster: Burden of disease in France
Chiappe, S. G., Sarazin, M., Turbelin, C., Lasserre, A., Pelat, C., Bonmarin, I., Chosidow, O., Blanchon, T., & Hanslik, T. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.09.074 · Cited by 76
Sociodemographic characteristics and chronic medical conditions as risk factors for herpes zoster
Esteban-Vasallo, M. D., Domínguez‐Berjón, M. F., Gil-Prieto, R., Astray‐Mochales, J., & de Miguel, Á. G. (2014) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.28620 · Cited by 75
Li, Y., An, Z., Yin, D., Liu, Y., Huang, Z., Xu, J., Ma, Y., Tu, Q., Li, Q., & Wang, H. (2016) · PLoS ONE · doi:10.1371/journal.pone.0152660 · Cited by 75
Guignard, A. P., Greenberg, M. E., Lu, C., Rosillon, D., & Vannappagari, V. X. (2014) · Infection · doi:10.1007/s15010-014-0645-x · Cited by 73
Chao, D., Chien, Y.-Z., Yeh, Y., Hsu, P.-S., & Lian, I. (2011) · Epidemiology and Infection · doi:10.1017/s0950268811001786 · Cited by 73
Chen, H., Chen, Y., Chen, T., Lan, J., Lin, C., & Chen, D.-Y. (2011) · Clinics · doi:10.1590/s1807-59322011000700009 · Cited by 62
The epidemiology of herpes zoster and its complications in Medicare cancer patients
Yenikomshian, M. A., Guignard, A. P., Haguinet, F., LaCasce, A. S., Skarin, A. T., Trahey, A., Karner, P., & Duh, M. S. (2015) · BMC Infectious Diseases · doi:10.1186/s12879-015-0810-6 · Cited by 62
Increased Risk of Herpes Zoster Infection in Patients With Inflammatory Bowel Diseases in Korea
Chang, K., Lee, H., Kim, Y., Kim, S., Kim, S., Lee, S.-H., Song, E. M., Hwang, S. W., Park, S. H., Yang, D., et al. (2018) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.05.024 · Cited by 61
Sato, K., Adachi, K., Nakamura, H., Asano, K., Watanabe, A., Adachi, R., Kiuchi, M., Kobayashi, K., Matsuki, T., Kaise, T., et al. (2016) · The Journal of Dermatology · doi:10.1111/1346-8138.13639 · Cited by 59
Risk of Herpes Zoster in CKD: A Matched-Cohort Study Based on Administrative Data
Wu, M., Hsu, Y., Su, C.-L., Lin, Y., & Lin, H. (2012) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2012.03.018 · Cited by 58
Risk Factors for Herpes Zoster Among Adults
Marin, M., Harpaz, R., Zhang, J., Wollan, P. C., Bialek, S. R., & Yawn, B. P. (2016) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofw119 · Cited by 57
Risk of Herpes Zoster in Patients Treated With Long-term Hemodialysis: A Matched Cohort Study
Kuo, C.-C., Lee, C., Lee, I., Ho, S., & Yang, C. (2011) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2011.10.049 · Cited by 56
Zhang, J. X., Joesoef, R. M., Białek, S., et al. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis937 · Cited by 56
Asthma as a risk factor for zoster in adults: A population-based case-control study
Kwon, H. J., Bang, D. W., Kim, E. N., Wi, C., Yawn, B. P., Wollan, P. C., Lahr, B. D., Ryu, E., & Juhn, Y. J. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.10.032 · Cited by 54
Clinical manifestations of herpes zoster
Oxman, M. N. (2000) · Cambridge University Press eBooks · doi:10.1017/cbo9780511601194.015 · Cited by 53
Epidemiology and costs of herpes zoster: Background data to estimate the impact of vaccination
Legami, V. D., Gianino, M. M., Atti, M. L. C. D., Massari, M., Migliardi, A., Tomba, G. S., & Zotti, C. M. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.07.049 · Cited by 52
Herpes Zoster Knowledge, Prevalence, and Vaccination Rate by Race
Lee, T. J., Hayes, S., Cummings, D. M., Cao, Q., Carpenter, K., Heim, L., & Edwards, H. E. (2013) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2013.01.120154 · Cited by 52
Herpes zoster surveillance using electronic databases in the Valencian Community (Spain)
Talamante, N. M., Díez‐Domingo, J., Martínez-Úbeda, S., Puig‐Barberà, J., Alemán-Sánchez, S., & Pérez–Breva, L. (2013) · BMC Infectious Diseases · doi:10.1186/1471-2334-13-463 · Cited by 49
Liu, B. C., Heywood, A. E., Reekie, J., Banks, E., Kaldor, J. M., McIntyre, P. B., Newall, A. T., & MacIntyre, C. R. (2015) · Epidemiology and Infection · doi:10.1017/s0950268814003653 · Cited by 46
Chen, D., Li, H., Xie, J., Zhan, Z., Liang, L., & Yang, X. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.5297 · Cited by 45
Kovac, M., Lal, H., Cunningham, A. L., Levin, M. J., Johnson, R. W., Cámpora, L., Volpi, A., & Heineman, T. C. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.02.029 · Cited by 45
Family history and herpes zoster risk in the era of shingles vaccination
Hernandez, P. O., Javed, S., Mendoza, N., Lapolla, W. J., Hicks, L. D., & Tyring, S. K. (2011) · Journal of Clinical Virology · doi:10.1016/j.jcv.2011.08.014 · Cited by 44
Tsai, S., Yang, T.-Y., Lin, C., Tsai, Y., Kuo, C. ‐., & Kao, C. (2014) · International Journal of Clinical Practice · doi:10.1111/ijcp.12508 · Cited by 42
Statins and the Risk of Herpes Zoster: A Population-Based Cohort Study
Antoniou, T., Zheng, H. Y., Singh, S., Juurlink, D. N., Mamdani, M., & Gomes, T. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit745 · Cited by 42
Keating, G. M. (2016) · BioDrugs · doi:10.1007/s40259-016-0180-7 · Cited by 42
Lin, S., Liu, J.-H., Lin, C., Tsai, I., Chen, P., Chung, C., Liu, Y., Wang, I., Lin, H., & Huang, C.-C. (2012) · American Journal of Nephrology · doi:10.1159/000339004 · Cited by 41
Risk and impact of herpes zoster among COPD patients: a population-based study, 2009–2014
Muñoz-Quiles, C., López‐Lacort, M., & Díez‐Domingo, J. (2018) · BMC Infectious Diseases · doi:10.1186/s12879-018-3121-x · Cited by 38
Ke, C.-C., Lai, H., Lin, C., Hung, C.-J., Chen, D.-Y., Sheu, W. H., & Lui, P.-W. (2016) · PLoS ONE · doi:10.1371/journal.pone.0146750 · Cited by 37
Association of Herpes Zoster and Type 1 Diabetes Mellitus
Chen, H., Lin, I., Chen, H.-J., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0155175 · Cited by 36
Herpes zoster and HIV-1 infection in a rural Ugandan cohort
Morgan, D., Mahé, C., Malamba, S. S., Okongo, M. J., Mayanja, B. N., & Whitworth, J. A. G. (2001) · AIDS · doi:10.1097/00002030-200101260-00012 · Cited by 34
Herpes Zoster Incidence in Inflammatory Bowel Disease Patients: A Population-Based Study
Côté-Daigneault, J., Bessissow, T., Nicolae, M. V., Nie, R., Bitton, A., Lakatos, P. L., & Brassard, P. (2018) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izy311 · Cited by 33
Cuenca, A. M. C., Díez‐Domingo, J., Rodríguez, M. S.-M., Puig‐Barberà, J., & Navarro-Pérez, J. (2010) · BMC Family Practice · doi:10.1186/1471-2296-11-33 · Cited by 32
Adult asthma is associated with an increased risk of herpes zoster: A population-based cohort study
Peng, Y., Fang, H.-Y., Wu, B., Kao, C., Chen, H.-J., Hsia, T., & Liao, W.-C. (2016) · Journal of Asthma · doi:10.1080/02770903.2016.1211142 · Cited by 29
Psychological Stress as a Trigger for Herpes Zoster: Might the Conventional Wisdom Be Wrong?
Harpaz, R., Leung, J. W., Brown, C. J., & Zhou, F. J. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu889 · Cited by 26
Matthews, A., Turkson, M., Forbes, H. J., Langan, S., Smeeth, L. L., & Bhaskaran, K. (2016) · British Journal of Dermatology · doi:10.1111/bjd.14815 · Cited by 25
Schmidt, S. A. J., Vestergaard, M., Pedersen, H. S., Schønheyder, H. C., Thomas, S. L., Smeeth, L. L., Mansfield, K. E., Sørensen, H. T., Forbes, H. J., & Langan, S. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw840 · Cited by 24
Wu, P., Lin, Y., Lin, C.-Y., Huang, M., Chang, W., & Chang, W.-P. (2015) · BMC Infectious Diseases · doi:10.1186/s12879-015-0747-9 · Cited by 22
Lin, S., Liu, J., Yeh, H.-Z., Lin, C., Tsai, I., Chen, P.-C., Sung, F. C., Yang, Y., Huang, C., Morisky, D. E., et al. (2014) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-014-2143-6 · Cited by 22
Gershon, A. A., Marin, M., & Seward, J. F. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35761-6.00062-6 · Cited by 22
Schmidt, S. A. J., Langan, S., Pedersen, H. S., Schønheyder, H. C., Thomas, S. L., Smeeth, L. L., Mansfield, K. E., Sørensen, H. T., Forbes, H. J., & Vestergaard, M. (2017) · American Journal of Epidemiology · doi:10.1093/aje/kwx338 · Cited by 21
Herpes zoster is associated with herpes simplex and other infections in under 60 year-olds
Ogunjimi, B., Buntinx, F., Bartholomeeusen, S., Terpstra, I., haes, I. D., Willem, L., Elli, S., Bilcke, J., Damme, P. V., Coenen, S., et al. (2014) · Journal of Infection · doi:10.1016/j.jinf.2014.08.016 · Cited by 19
Tung, Y.-C., Tu, H., Tsai, W., Chen, C., Su, C., Shi, H., & Lin, C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0129043 · Cited by 17
Statins can increase the risk of herpes zoster infection in Asia
Chen, H.-H., Lin, C., Yeh, C.-J., Yeh, S.-Y., & Kao, C. (2015) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-015-2372-3 · Cited by 17
Statins increase the risk of herpes zoster: A propensity score-matched analysis
Kim, M., Yun, S., Lee, S., Choi, S., Kim, Y. S., Woo, J. H., & Kim, S. (2018) · PLoS ONE · doi:10.1371/journal.pone.0198263 · Cited by 16
Herpes Zoster Is Associated with Prior Statin Use: A Population-Based Case-Control Study
Chung, S., Tsai, M.-C., Liu, S., Lin, H., & Kang, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111268 · Cited by 15
Suo, L., Li, L., Li, J., Sun, M., Wang, H., Peng, X., Yang, F., Pang, X., Marin, M., & Wang, C. (2017) · BMC Infectious Diseases · doi:10.1186/s12879-017-2416-7 · Cited by 14
Family history of zoster and risk of developing herpes zoster
Tseng, H. F., Chi, M., Hung, P., Harpaz, R., Schmid, D. S., LaRussa, P. S., Sy, L. S., Luo, Y., Holmquist, K. J., Takhar, H. S., et al. (2017) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2017.11.016 · Cited by 13
Hua, C. L., Bardo, A. R., & Brown, J. S. (2018) · Journal of the National Medical Association · doi:10.1016/j.jnma.2018.01.006 · Cited by 13
Recombinant Zoster Vaccine (Shingrix) to Prevent Herpes Zoster
Sly, J., & Harris, A. L. (2018) · Nursing for Women s Health · doi:10.1016/j.nwh.2018.07.004 · Cited by 12
Cited by
Lemmetyinen, R., Karjalainen, J., But, A., Renkonen, R., Pekkanen, J., Haukka, J., & Toppila-Salmi, S. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-053133 · Cited by 7
Metadata
- Authors
- Marra, F., Parhar, K., Huang, B., & Vadlamudi, N.
- Venue
- Open Forum Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-01-01
- Volume
- 7
- Issue
- 1
- Pages
- ofaa005-ofaa005
- ISSN
- 2328-8957 (ISSN-L)
- OpenAlex
- W2998977499
- Cited by
- 335
- References
- 108
- FWCI
- 7.65
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.